Microbix Biosystems (MBX) Competitors

Fennec Pharmaceuticals (TSE:FRX) and Microbix Biosystems (TSE:MBX) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, community ranking, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations.

Do analysts prefer FRX or MBX?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fennec Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	4.00
Microbix Biosystems	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has preferable valuation and earnings, FRX or MBX?

Microbix Biosystems has lower revenue, but higher earnings than Fennec Pharmaceuticals. Fennec Pharmaceuticals is trading at a lower price-to-earnings ratio than Microbix Biosystems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fennec Pharmaceuticals	C$34.86M	4.69	-C$800.44K	-C$0.06	-143.65
Microbix Biosystems	C$24.42M	2.43	C$3.39M	C$0.03	17.14

Is FRX or MBX more profitable?

Microbix Biosystems has a net margin of 13.86% compared to Fennec Pharmaceuticals' net margin of -2.30%. Fennec Pharmaceuticals' return on equity of 29.94% beat Microbix Biosystems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fennec Pharmaceuticals	-2.30%	29.94%	8.88%
Microbix Biosystems	13.86%	12.65%	3.82%

Do institutionals and insiders hold more shares of FRX or MBX?

52.8% of Fennec Pharmaceuticals shares are owned by institutional investors. Comparatively, 0.4% of Microbix Biosystems shares are owned by institutional investors. 16.2% of Fennec Pharmaceuticals shares are owned by insiders. Comparatively, 14.0% of Microbix Biosystems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Does the MarketBeat Community believe in FRX or MBX?

Fennec Pharmaceuticals received 34 more outperform votes than Microbix Biosystems when rated by MarketBeat users. However, 70.71% of users gave Microbix Biosystems an outperform vote while only 69.80% of users gave Fennec Pharmaceuticals an outperform vote.

Company	Underperform	Outperform
Fennec Pharmaceuticals	Outperform Votes 104 69.80%	Underperform Votes 45 30.20%
Microbix Biosystems	Outperform Votes 70 70.71%	Underperform Votes 29 29.29%

Does the media refer more to FRX or MBX?

In the previous week, Fennec Pharmaceuticals and Fennec Pharmaceuticals both had 1 articles in the media. Microbix Biosystems' average media sentiment score of 1.03 beat Fennec Pharmaceuticals' score of 0.67 indicating that Microbix Biosystems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fennec Pharmaceuticals	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Microbix Biosystems	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk & volatility, FRX or MBX?

Fennec Pharmaceuticals has a beta of 0.25, meaning that its share price is 75% less volatile than the S&P 500. Comparatively, Microbix Biosystems has a beta of 0.34, meaning that its share price is 66% less volatile than the S&P 500.

Summary

Fennec Pharmaceuticals beats Microbix Biosystems on 9 of the 16 factors compared between the two stocks.